Compounded Semaglutide Providers in 2026 — Ranked & Reviewed

Compounded semaglutide is a low-cost alternative to brand-name Wegovy and Ozempic, made by 503A and 503B pharmacies under physician supervision. We ranked the most reputable telehealth clinics offering compounded semaglutide in 2026 by price, pharmacy verification, clinical care, and shipping. Every provider on this list ships nationwide.

Lowest verified price: $49/mo411 providers compared

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed

411 compounded semaglutide providers compared · independently scored against our six-factor methodology.

Quick Picks: Top 5

#ProviderScore
1CoreAge RxVisit
2FoundVisit
3CollectiveVisit
4Enhance MDVisit
5bmiMDVisit

Compare the top providers at a glance

Logos, our editorial rating, price, medications, and coverage — the fastest way to narrow the list.

  • ★ Editor's Pick
    CoreAge Rx

    best overall value

    From /mo
    $99
    Flat at every dose
    Coverage
    50 states
    Medications
    SemaglutideTirzepatide
  • Nationwide Coverage
    Found

    mainstream telehealth GLP-1 access

    From /mo
    $99
    Coverage
    50 states
    Medications
    SemaglutideTirzepatide
  • Best Budget
    Collective

    the lowest flat medication price if you can absorb an annual membership fee

    From /mo
    $59
    Flat at every dose
    Coverage
    Check intake
    Medications
    SemaglutideTirzepatide
  • Enhance MD

    lab-monitored compounded GLP-1 with mandatory video visit

    From /mo
    $112
    Flat at every dose
    Coverage
    39 states
    Medications
    SemaglutideTirzepatide
  • bmiMD

    mainstream telehealth GLP-1 access

    From /mo
    $99
    Flat at every dose
    Coverage
    50 states
    Medications
    SemaglutideTirzepatide
  • Transparent Pricing
    RxSpan MD

    physician-led, pharmacy-transparent compounded GLP-1 with brand-name options

    From /mo
    $249
    Coverage
    50 states
    Medications
    SemaglutideTirzepatide
  • GobyMeds

    budget-conscious shoppers

    From /mo
    $93
    Coverage
    Check intake
    Medications
    SemaglutideTirzepatide
  • Oak

    compounded semaglutide and tirzepatide at a flat monthly price

    From /mo
    $133
    Flat at every dose
    Coverage
    Check intake
    Medications
    SemaglutideTirzepatide
6scored dimensions
411compounded semaglutide providers compared
100%verified against live provider sites
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

Detailed Reviews

1

CoreAge Rx

Verified partner

Best for: best overall value

8.3

CoreAge Rx offers LegitScript-certified compounded semaglutide and tirzepatide with free 2-day shipping to all 50 states. Backed by licensed physicians and 24/7 support, it delivers the most competitive pricing in the compounded GLP-1 space.

Score Breakdown

Value25%
8.5
Effectiveness25%
8.5
User Experience15%
8.5
Trust & Safety15%
7.8
Accessibility10%
8
Support10%
8.4

Pros

  • ✓LegitScript certified — rigorous pharmacy standards
  • ✓Free 2-day shipping nationwide
  • ✓Both semaglutide and tirzepatide available
  • ✓Lowest per-month pricing in the compounded segment
  • ✓24/7 support team
  • ✓All 50 states covered

Cons

  • ✗Compounded only — no brand-name Ozempic or Wegovy
  • ✗Newer brand with fewer independent reviews than legacy players
2

Found

Verified partner

Best for: mainstream telehealth GLP-1 access

8.3

Personalized weight care platform with a self-pay membership model plus medication costs.

Score Breakdown

Value25%
8.5
Effectiveness25%
9
User Experience15%
8
Trust & Safety15%
7.3
Accessibility10%
8.5
Support10%
7.5

Pros

  • ✓Aggressively low monthly pricing
  • ✓Both semaglutide and tirzepatide available
  • ✓Compounded GLP-1 access

Cons

  • ✗Limited public information on program details
3

Collective

Verified partner

Best for: the lowest flat medication price if you can absorb an annual membership fee

8.3

Collective (collective.org) is a membership-based telehealth platform from the founder of Thrive Market, selling compounded semaglutide and tirzepatide at a flat price on every dose. Medication is billed separately from a required annual membership, and the program bundles unlimited clinician messaging, dietitian access and express cold shipping.

Score Breakdown

Value25%
9.4
Effectiveness25%
8.2
User Experience15%
8
Trust & Safety15%
7.2
Accessibility10%
7.4
Support10%
8.4

Pros

  • ✓The lowest published compounded GLP-1 medication prices we track — $59/month semaglutide and $69/month tirzepatide
  • ✓Flat pricing at every dose, so titrating up does not raise the bill
  • ✓Unlimited clinician messaging and registered-dietitian access are included rather than upsold
  • ✓21-day free trial on the membership before the annual fee is charged

Cons

  • ✗The advertised $59 and $69 exclude a mandatory $199 annual membership — the real first-year cost is $907 and $1,027
  • ✗Membership fees are non-refundable and no partial-period refunds are given
  • ✗Compounding pharmacies are described only as 'independent, third-party licensed pharmacies' and are never named
  • ✗State availability is not published on the marketing site
4

Enhance MD

Verified partner

Best for: lab-monitored compounded GLP-1 with mandatory video visit

8.2

Enhance MD pairs compounded semaglutide and tirzepatide with mandatory baseline metabolic labs at Quest Diagnostics and a synchronous video visit with a board-certified clinician — a more rigorous onboarding than the async-only compounded GLP-1 model most telehealth providers use. Three tiers (Core semaglutide, Advanced tirzepatide, Elite combined) plus $100-off-first-order intro pricing ($112 first month on Core with code SUMMER100).

Score Breakdown

Value25%
7
Effectiveness25%
9
User Experience15%
8.5
Trust & Safety15%
8
Accessibility10%
8.5
Support10%
8.9

Pros

  • ✓Baseline and ongoing metabolic labs (CMP, lipids, TSH, HbA1c) at Quest every 6 months — rare for compounded GLP-1
  • ✓Mandatory video visit with a US-licensed MD or NP before your first prescription — not a pure questionnaire model
  • ✓Three tiers, including a combined semaglutide + tirzepatide Elite plan ($322/mo) for patients plateaued on one GLP-1
  • ✓Uses LegitScript-certified 503A pharmacies (Tru Meds Rx, Strive Pharmacy, Pharmacy Hub)
  • ✓Intro pricing via $100 off your first order (code SUMMER100): $112 Core, $180 Advanced, $222 Elite first month
  • ✓Unlimited clinician messaging and dose-adjustment support included

Cons

  • ✗Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
  • ✗Not available in 10 states: AL, AR, GA, HI, LA, MS, MO, SC, TN, WV
  • ✗Mandatory lab work adds 5–10 days to onboarding vs async-only competitors
  • ✗No insurance accepted — cash pay, HSA/FSA eligible
  • ✗Intro discount applies only to the first order — ongoing rates are $212–$322/mo on 12-month plans, or $249–$379/mo month-to-month
5

bmiMD

Verified partner

Best for: mainstream telehealth GLP-1 access

8.1

Medical weight loss clinic offering GLP-1 prescriptions through telehealth.

Score Breakdown

Value25%
9
Effectiveness25%
8
User Experience15%
7.5
Trust & Safety15%
7.3
Accessibility10%
8.5
Support10%
8

Pros

  • ✓Both semaglutide and tirzepatide available

Cons

  • ✗Cheapest advertised rates require a 12-month prepaid plan — month-to-month is $129 for semaglutide and $139 for sermorelin injection

How to choose a compounded semaglutide provider

Compounded semaglutide is a lower-cost alternative to Wegovy and Ozempic, made by 503A/503B pharmacies. It uses the same active ingredient, but it is not FDA-approved, so the pharmacy behind it is everything.

What to look for

  • 503A or 503B pharmacy, named. The provider should name its compounding pharmacy and its accreditation. Unnamed 'US-based pharmacy partners' with no detail is a transparency gap.
  • Injectable over oral. Injectable compounded semaglutide mirrors the studied product. Oral/sublingual compounded versions have far weaker absorption evidence — treat bold oral claims with caution.
  • No surprise additives. Some pharmacies add B6/B12 or other agents. That's not inherently bad, but you should know exactly what's in the vial before you start.

Red flags to avoid

  • No named pharmacy or LegitScript listing. A legitimate compounded-GLP-1 provider names its 503A/503B pharmacy partner and carries LegitScript certification. If neither is disclosed, you can't verify what you're injecting.
  • Async-only, no real clinician review. A prescriber should review your intake and be reachable for dose questions. Instant approval with no way to reach a clinician is a safety gap.
  • Teaser pricing that hides the real cost. A low 'first month' price that jumps at higher doses, or a membership fee stacked on top of the medication, can double the true monthly total. Confirm the ongoing, all-in price before you pay.
  • Weight-loss claims for B12, MIC, or HCG shots. Only GLP-1 injections have trial evidence for weight loss. A clinic selling B12, lipotropic, or HCG shots as a weight-loss treatment is a red flag.

Every provider ranked above is scored against these criteria across our six-dimension methodology, and prices are re-verified against each provider’s live site.

How we rank & what counts as “legit”

Every provider in this ranking is scored against our published six-factor rubric[1] — value, effectiveness, user experience, trust & safety, accessibility, and support. Compounded GLP-1s from licensed 503A and 503B pharmacies are legal under federal compounding law[2], with additional tolerances historically allowed while semaglutide and tirzepatide were on the FDA Drug Shortage List[3].

Brand-name Wegovy, Zepbound, Ozempic, and Mounjaro are separately FDA-approved under their own NDA numbers[4][5]. Published Phase 3 efficacy for semaglutide 2.4 mg (~14.9% mean weight loss over 68 weeks) comes from the STEP 1 trial[6], and for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) from SURMOUNT-1[7]; the SURMOUNT-5 head-to-head published in 2025 compared the two directly[8].

Insurance coverage for anti-obesity medications varies widely by state Medicaid program and commercial plan[9][10]. Compounded and brand-name GLP-1s are generally FSA/HSA eligible with a prescription under IRS Publication 502[11].

Always verify pricing and state availability on the provider's website before signing up.How our reviews work →
Looking for the pharmacies behind these compounded medications? See our compounding pharmacy directory with 503A/503B status, PCAB accreditation, and regulatory standing.

Frequently Asked Questions

No — it is available through many telehealth providers after a brief online medical consultation, and it ships nationwide. The harder part is choosing a legitimate provider: look for a 503A or 503B compounding pharmacy, LegitScript certification, and transparent pricing before checkout. Every provider ranked above prescribes compounded semaglutide online.
Yes. Compounded semaglutide is most often a subcutaneous injection, but some pharmacies also offer oral (sublingual or troche) versions, and some add B6/B12 or other additives. The injectable form most closely mirrors the FDA-approved product studied in trials; oral compounded versions have far less evidence behind their absorption.
Semaglutide is not recommended if you have a personal or family history of medullary thyroid carcinoma or MEN 2, a prior serious reaction to a GLP-1, or if you are pregnant or planning pregnancy. A history of pancreatitis, gallbladder disease, or severe GI conditions calls for caution. A prescriber screens for these during the intake — a provider that skips that screening is a red flag.
Each provider is evaluated across six weighted dimensions: Value (25%), Effectiveness (25%), User Experience (15%), Trust & Safety (15%), Accessibility (10%), and Support (10%). We research publicly available information, user reviews, clinical evidence, and pricing data, then compute a weighted overall score out of 10.
Each provider's score is computed independently using the six-dimension methodology, and a commercial relationship never changes a provider's underlying score — you can see every provider's full score on its card. Some providers have affiliate agreements with us, meaning we earn a commission if you click through and make a purchase. On our highest-commercial-intent lists — including the semaglutide, tirzepatide, compounded and cheapest molecule lists, the weight-loss injection and shot lists, and the fitness-app list — we feature affiliate partners in the top positions; on every other list the order follows the score (or, for the cheapest lists, the lowest price) directly. This placement is disclosed here and on our methodology and affiliate-disclosure pages.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources & methodology — as of October 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  5. 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  8. 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
  9. 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  10. 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
  11. 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.